Filana Therapeutics
FLNA
75 hedge funds and large institutions have $137M invested in Filana Therapeutics in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 8 closing their positions.
2,002% more call options, than puts
Call options by funds: $988K | Put options by funds: $47K
175% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 8
50% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 16
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
21% more funds holding
Funds holding: 62 → 75 (+13)
18% more capital invested
Capital invested by funds: $115M → $137M (+$21.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
+$3.71M |
| 2 |
MSP
Madison Street Partners
Denver,
Colorado
|
+$2.57M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.14M |
| 4 |
Morgan Stanley
New York
|
+$961K |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$866K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.57M |
| 2 |
BC
Broadfin Capital
New York
|
-$2.27M |
| 3 |
SC
Sophrosyne Capital
New York
|
-$1.64M |
| 4 |
6CM
683 Capital Management
New York
|
-$1.35M |
| 5 |
Renaissance Technologies
New York
|
-$777K |
FLNA Hedge Fund Activity: Q1 2014 in Review
75 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2014, worth a combined $137M — up 18% from $115M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new FLNA positions and 8 closed out — a net gain of 14 holders — while 24 added to existing stakes and 16 trimmed.
The largest buyer was First Eagle Investment Management, adding an estimated $3.71M. The largest seller was Great Point Partners, cutting an estimated $2.57M.
- 75 institutional investors held Filana Therapeutics (FLNA) as of Q1 2014, up from 62 in Q4 2013.
- Funds reported $137M of Filana Therapeutics stock for Q1 2014, up 18% quarter-over-quarter.
- 22 funds opened new Filana Therapeutics positions in Q1 2014 and 8 closed out, a net change of +14 holders.
- The largest Filana Therapeutics buyer in Q1 2014 was First Eagle Investment Management, an estimated $3.71M added.
- The largest Filana Therapeutics seller in Q1 2014 was Great Point Partners, an estimated $2.57M sold.
Based on aggregated 13F filings for Q1 2014.